According to the Zhitong Finance App, Fosun Pharmaceutical (02196) announced that the company intends to provide joint liability guarantee guarantees for working capital loans with a principal amount of not more than RMB 200 million applied for by the holding subsidiary Fosun Pharmaceutical Industry from the Bank of Beijing; the company intends to provide a maximum joint liability guarantee guarantee for the holding subsidiary Recovery Health's application to Bohai Bank for domestic reverse factoring business buyer credit lines of debt under credit lines of no more than RMB 200 million; the company's holding subsidiary Fosun Diagnosis plans to diagnose its holding subsidiary Fuchang Xiang Xiang Xiang Where the principal amount applied for by Shabank does not exceed RMB 150 million Debts under financing provide a maximum joint liability guarantee. In addition, Fosun Diagnoses Changsha also plans to provide a maximum joint liability guarantee for such debts using its buildings and land use rights under construction located in the High-tech Zone of Changsha City.
As of July 21, 2023, including this guarantee, the Group's actual guarantee amount for Fosun Pharmaceutical Industry is equivalent to RMB 9.638 billion, the guarantee amount for Recovery Health is RMB 200 million, and the guarantee amount for Fosun's diagnosis of Changsha is RMB 150 million.